NCT02144025View on ClinicalTrials.gov

Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Graft-Versus-Host Disease
Interventions
DRUG

Cyclosporine

Use of topical cyclosporine (one drop of cyclosporine in each eye, twice a day for 12 months)

Trial Locations (1)

64460

Servicio de Hematologia Hospital Universitario Dr Jose Eleuterio Gonzalez, Monterrey

All Listed Sponsors
lead

Hospital Universitario Dr. Jose E. Gonzalez

OTHER

NCT02144025 - Prevention of Ocular Graft-Versus-Host Disease With Topical Cyclosporine in Recipients of Allogeneic HSCT | Biotech Hunter | Biotech Hunter